MYGNMyriad Genetics, Inc.

$454M

FY 2014 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$723M-7.1% YoY

Gross Profit

$576M79.6% margin

Operating Income

$134M18.6% margin

Net Income

$80M11.1% margin

EPS (Diluted)

$1.08

Cash Flow

Operating Cash Flow

$141M

Free Cash Flow

$117M

Stock-Based Comp.

$46M

Balance Sheet

Total Assets

$766M

Total Liabilities

$104M

Stockholders' Equity

$662M

Cash & Equivalents

$64M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$723M	$778M	-7.1%
Gross Profit	$576M	$669M	-13.9%
Operating Income	$134M	$274M	-51.1%
Net Income	$80M	$176M	-54.5%

MYGN FY 2014 Earnings — Myriad Genetics, Inc. Revenue & Financial Results | Market Cap Arena